Literature DB >> 19242462

Alzheimer's disease: A prion protein connection.

Moustapha Cisse, Lennart Mucke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19242462     DOI： 10.1038/4571090a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  A specific amyloid-beta protein assembly in the brain impairs memory.

Authors:  Sylvain Lesné; Ming Teng Koh; Linda Kotilinek; Rakez Kayed; Charles G Glabe; Austin Yang; Michela Gallagher; Karen H Ashe
Journal:  Nature       Date:  2006-03-16       Impact factor: 49.962

2.  Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

Authors:  Nicola Origlia; Massimo Righi; Simona Capsoni; Antonino Cattaneo; Fang Fang; David M Stern; John Xi Chen; Ann Marie Schmidt; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

3.  Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.

Authors:  Jeannie Chin; Jorge J Palop; Jukka Puoliväli; Catherine Massaro; Nga Bien-Ly; Hilary Gerstein; Kimberly Scearce-Levie; Eliezer Masliah; Lennart Mucke
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

4.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

5.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

6.  Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.

Authors:  Ganesh M Shankar; Brenda L Bloodgood; Matthew Townsend; Dominic M Walsh; Dennis J Selkoe; Bernardo L Sabatini
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

Review 7.  The prion's elusive reason for being.

Authors:  Adriano Aguzzi; Frank Baumann; Juliane Bremer
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

8.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

Review 9.  Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.

Authors:  Yann Verdier; Márta Zarándi; Botond Penke
Journal:  J Pept Sci       Date:  2004-05       Impact factor: 1.905

10.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962
View more
  16 in total

1.  Gold nanorods 3D-supercrystals as surface enhanced Raman scattering spectroscopy substrates for the rapid detection of scrambled prions.

Authors:  Ramón A Alvarez-Puebla; Ashish Agarwal; Pramit Manna; Bishnu P Khanal; Paula Aldeanueva-Potel; Enrique Carbó-Argibay; Nicolas Pazos-Pérez; Leonid Vigderman; Eugene R Zubarev; Nicholas A Kotov; Luis M Liz-Marzán
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

2.  Stability analysis of a steady state of a model describing Alzheimer's disease and interactions with prion proteins.

Authors:  Mohammed Helal; Angélique Igel-Egalon; Abdelkader Lakmeche; Pauline Mazzocco; Angélique Perrillat-Mercerot; Laurent Pujo-Menjouet; Human Rezaei; Léon M Tine
Journal:  J Math Biol       Date:  2018-08-11       Impact factor: 2.259

Review 3.  Molecular and genetic inflammation networks in major human diseases.

Authors:  Yongzhong Zhao; Christian V Forst; Camil E Sayegh; I-Ming Wang; Xia Yang; Bin Zhang
Journal:  Mol Biosyst       Date:  2016-07-19

4.  Copper Binding Regulates Cellular Prion Protein Function.

Authors:  Xuan T A Nguyen; Thanh Hoa Tran; Dan Cojoc; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

Review 5.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

6.  Cu(II)-Zn(II) Cross-Modulation in Amyloid-Beta Peptide Binding: An X-ray Absorption Spectroscopy Study.

Authors:  Emiliano De Santis; Velia Minicozzi; Olivier Proux; Giancarlo Rossi; K Ishara Silva; Matthew J Lawless; Francesco Stellato; Sunil Saxena; Silvia Morante
Journal:  J Phys Chem B       Date:  2015-12-21       Impact factor: 2.991

7.  Alzheimer's disease: analysis of a mathematical model incorporating the role of prions.

Authors:  Mohamed Helal; Erwan Hingant; Laurent Pujo-Menjouet; Glenn F Webb
Journal:  J Math Biol       Date:  2013-10-22       Impact factor: 2.259

8.  PrP106-126 and Aβ 1-42 peptides induce BV-2 microglia chemotaxis and proliferation.

Authors:  Jian Tu; LiFeng Yang; XiangMei Zhou; KeZong Qi; JinGuo Wang; Mohammed Kouadir; LiHua Xu; XiaoMin Yin; DeMing Zhao
Journal:  J Mol Neurosci       Date:  2013-11-13       Impact factor: 3.444

9.  Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases.

Authors:  Urmila Basu; Le Luo Guan; Stephen S Moore
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

10.  Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.

Authors:  Jo V Rushworth; Heledd H Griffiths; Nicole T Watt; Nigel M Hooper
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.